• Home
  • Ricardo J. Fittipaldi-Fernandez
Ricardo J. Fittipaldi-Fernandez

Ricardo J. Fittipaldi-Fernandez
  • CEO at Endogastro

About

41
Publications
2,206
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
183
Citations
Current institution
Endogastro
Current position
  • CEO

Publications

Publications (41)
Article
Full-text available
Background and study aims A comparative study was conducted to evaluate the efficacy of argon plasma coagulation (APC) therapy in treating post Roux-en-Y gastric bypass (RYGB) weight regain and the incidence of complications related to this procedure, using a sham treatment group as a control. Patients and methods Forty-one patients with a minimum...
Article
Full-text available
IntroductionArgon plasma coagulation (APC) alone is effective and safe at treating weight regain following Roux-en-Y gastric bypass (RYGB). However, technical details of the treatment vary widely among studies. Therefore, we aimed to create good clinical practice guidelines through a modified Delphi consensus, including experts from the collaborati...
Article
Full-text available
Background: To analyze the results regarding weight loss and complications related to the Spatz3® adjustable intragastric balloon (IGB) in Brazil. Methods: This randomized prospective study covered patients who had undergone treatment using a Spatz3® adjustable IGB between October 2016 and June 2018 at a private clinic in Rio de Janeiro, Brazil....
Article
Full-text available
Background: Endoscopic methods, especially the intragastric balloon (IGB), have been shown to be effective for the treatment of excess weight. This study aimed to assess the tolerance, complications, and efficacy of excess weight treatment with a non-adjustable IGB during 6 months. Methods: A total of 5874 patients treated with a liquid-filled I...
Article
Background and Aims Endoscopic transoral outlet reduction (TORe) has been used to manage weight regain after Roux-en-Y gastric bypass (RYGB). We conducted a meta-analysis to summarize the efficacy and safety of the 2 most commonly used techniques: full-thickness suturing plus argon plasma mucosal coagulation (ft-TORe) and argon plasma mucosal coagu...
Chapter
Around 2 years ago, Brazil approved the use of the liquid-filled adjustable intragastric balloon (Spatz® ⁻ Spatz Medical, Great Neck, NY, USA). The volume of the Spatz® balloon can be increased or diminished at any time of the treatment. Also, it has a maximum indwelling time of 1 year. The rate of adverse events is similar between the traditional...
Chapter
The adjustable intragastric balloon (Spatz® – Spatz Medical, Great Neck, NY, USA) is a water-filled device that may indwell in the stomach for 1 Year. It is an attractive device, but implantation, adjustment, and removal procedures have some particularities. This chapter describes the standard and alternative techniques to handle these procedures a...
Article
Full-text available
Background Obesity is accompanied by adipose tissue remodeling characterized by increased production of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, leptin and resistin and reduced secretion of adiponectin, which favors inflammation, metabolic disorders, and cardiovascular diseases. Although intragastric balloon (IGB) can be considered...
Article
Full-text available
Background Obesity is an important risk factor for several chronic diseases and also is associated with worse quality of life. Intragastric balloon (IGB) is an effective method for weight loss. Although changes in lifestyle are critical to weight loss during and after IGB therapy, only a few studies evaluated dietary intake and none evaluated chang...
Article
Full-text available
Introdução: A obesidade é uma doença grave, com morbidade e mortalidade substanciais. Os balões intragástricos (IGB) estão em uso desde a década de 1980. Durante a evolução de seu uso, complicações como migração do dispositivo e até perfurações gástricas graves podem ocorrer necessitando de cirurgia laparoscópica para resolução do caso. Relatam-se...
Article
Full-text available
Background and study aims Obesity is a serious disease, resulting in significant morbidity and mortality. Intragastric balloons (IGBs) have been in use since the 1980s. After the insertion of an IGB, complications such as migration of the device and even severe gastric perforation can occur, requiring laparoscopic surgery. Here, we report three cas...
Article
Full-text available
Background: Several studies conducted in adults suggest that intragastric balloon (IGB) is an effective and safe method for weight loss. Although the prevalence of obesity in adolescents has increased in recent years, the outcomes of IGB treatment in this age group are not known. The aim of this study was to evaluate the safety and efficacy of IGB...

Network

Cited By